MX2008012880A - Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local. - Google Patents
Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local.Info
- Publication number
- MX2008012880A MX2008012880A MX2008012880A MX2008012880A MX2008012880A MX 2008012880 A MX2008012880 A MX 2008012880A MX 2008012880 A MX2008012880 A MX 2008012880A MX 2008012880 A MX2008012880 A MX 2008012880A MX 2008012880 A MX2008012880 A MX 2008012880A
- Authority
- MX
- Mexico
- Prior art keywords
- vulvar
- vaginal
- methods
- administration
- prevention
- Prior art date
Links
- 206010030247 Oestrogen deficiency Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 229940035811 conjugated estrogen Drugs 0.000 abstract 4
- 206010003694 Atrophy Diseases 0.000 abstract 2
- 230000037444 atrophy Effects 0.000 abstract 2
- 239000000262 estrogen Substances 0.000 abstract 2
- 229940011871 estrogen Drugs 0.000 abstract 2
- 208000004746 Atrophic Vaginitis Diseases 0.000 abstract 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 abstract 1
- 208000004483 Dyspareunia Diseases 0.000 abstract 1
- -1 MPA Chemical compound 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 206010047791 Vulvovaginal dryness Diseases 0.000 abstract 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 abstract 1
- WAHQVRCNDCHDIB-QZYSPNBYSA-N [(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate Chemical compound O([C@@H]1C=C2C(C)=C[C@H]3[C@@H]4CC[C@]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)(OC(=O)C)C(C)=O)C(=O)CCC1CCCC1 WAHQVRCNDCHDIB-QZYSPNBYSA-N 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 201000006669 vulvar dystrophy Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a métodos para la prevención y tratamiento de condiciones que surgen de deficiencia de estrógeno local, tales como dispareunia, atrofia vulvar, atrofia vaginal, resequedad vaginal, comezón vulvar, comezón vaginal, ardor vulvar, ardor vaginal, distrofia vulvar, vaginitis atrófica o disfunción sexual menopáusica; en algunas modalidades, los métodos incluyen administración sistémica, por ejemplo oral, de un estrógeno, tal como estrógenos conjugados, y un progestágeno, tal como MPA, contemporáneamente con administración local de un estrógeno, por ejemplo, estrógenos conjugados; en algunas modalidades, los métodos incluyen la administración oral de estrógenos conjugados y MPA, y la administración vulvar, vaginal, o vulvar y vaginal, de estrógenos conjugados, por ejemplo, en una crema.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78951706P | 2006-04-05 | 2006-04-05 | |
| PCT/US2007/066042 WO2007118135A2 (en) | 2006-04-05 | 2007-04-05 | Methods for prevention and treatment of conditions arising from local estrogen deficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008012880A true MX2008012880A (es) | 2008-10-13 |
Family
ID=38523460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008012880A MX2008012880A (es) | 2006-04-05 | 2007-04-05 | Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070238713A1 (es) |
| EP (1) | EP2004200A2 (es) |
| JP (1) | JP2009532505A (es) |
| KR (1) | KR20080108120A (es) |
| CN (1) | CN101415427A (es) |
| AU (1) | AU2007234841A1 (es) |
| BR (1) | BRPI0709924A2 (es) |
| CA (1) | CA2644913A1 (es) |
| CR (1) | CR10259A (es) |
| EC (1) | ECSP088796A (es) |
| GT (1) | GT200800205A (es) |
| IL (1) | IL193810A0 (es) |
| MX (1) | MX2008012880A (es) |
| NO (1) | NO20083789L (es) |
| RU (1) | RU2008136024A (es) |
| WO (1) | WO2007118135A2 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100155594A1 (en) | 2008-12-23 | 2010-06-24 | Goldman Mildred M | Mass spectrometry assay for estrogenic compounds |
| BR112014012444B1 (pt) | 2011-11-23 | 2021-12-14 | Therapeuticsmd, Inc | Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010034340A1 (en) * | 2000-03-20 | 2001-10-25 | American Home Products Corporation | Hormone replacement therapy |
| MXPA03008366A (es) * | 2001-03-16 | 2004-11-12 | Wyeth Corp | Terapia de reemplazamiento de estrogenos. |
| AU2002309919B2 (en) * | 2001-05-16 | 2008-04-10 | Barr Laboratories, Inc. | Treatment of conditions relating to hormone deficiencies by administration of progestins |
-
2007
- 2007-04-05 MX MX2008012880A patent/MX2008012880A/es unknown
- 2007-04-05 CN CNA2007800124125A patent/CN101415427A/zh not_active Withdrawn
- 2007-04-05 WO PCT/US2007/066042 patent/WO2007118135A2/en not_active Ceased
- 2007-04-05 BR BRPI0709924-0A patent/BRPI0709924A2/pt not_active Application Discontinuation
- 2007-04-05 CA CA002644913A patent/CA2644913A1/en not_active Abandoned
- 2007-04-05 US US11/696,917 patent/US20070238713A1/en not_active Abandoned
- 2007-04-05 EP EP07760168A patent/EP2004200A2/en not_active Withdrawn
- 2007-04-05 KR KR1020087024302A patent/KR20080108120A/ko not_active Withdrawn
- 2007-04-05 RU RU2008136024/14A patent/RU2008136024A/ru not_active Application Discontinuation
- 2007-04-05 AU AU2007234841A patent/AU2007234841A1/en not_active Abandoned
- 2007-04-05 JP JP2009504473A patent/JP2009532505A/ja active Pending
-
2008
- 2008-08-28 CR CR10259A patent/CR10259A/es not_active Application Discontinuation
- 2008-09-01 IL IL193810A patent/IL193810A0/en unknown
- 2008-09-03 NO NO20083789A patent/NO20083789L/no not_active Application Discontinuation
- 2008-10-02 GT GT200800205A patent/GT200800205A/es unknown
- 2008-10-06 EC EC2008008796A patent/ECSP088796A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2008136024A (ru) | 2010-05-10 |
| KR20080108120A (ko) | 2008-12-11 |
| AU2007234841A1 (en) | 2007-10-18 |
| JP2009532505A (ja) | 2009-09-10 |
| WO2007118135A2 (en) | 2007-10-18 |
| ECSP088796A (es) | 2008-11-27 |
| CA2644913A1 (en) | 2007-10-18 |
| WO2007118135A3 (en) | 2008-04-24 |
| BRPI0709924A2 (pt) | 2011-07-26 |
| GT200800205A (es) | 2009-05-15 |
| EP2004200A2 (en) | 2008-12-24 |
| CR10259A (es) | 2008-11-26 |
| NO20083789L (no) | 2008-09-30 |
| IL193810A0 (en) | 2009-08-03 |
| US20070238713A1 (en) | 2007-10-11 |
| CN101415427A (zh) | 2009-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2008012880A (es) | Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local. | |
| NZ602698A (en) | Parenteral pharmaceutical form which releases aromatase inhibitor and gestagens, for the treatment of endometriosis | |
| MX2009004616A (es) | Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente. | |
| MX2010004353A (es) | Combinación anticonceptiva oral entiemética. | |
| WO2007085020A3 (en) | Method of treating atrophic vaginitis | |
| PE20080273A1 (es) | Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico | |
| MX2019005289A (es) | Composiciones de corticosteroides administradas oralmente. | |
| MY153976A (en) | Lh liquid formulations | |
| MX2009007254A (es) | Composiciones de tableta en tableta. | |
| ZA200703198B (en) | Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a Type 5 CGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women | |
| GT200800038A (es) | Metodo para prevenir la contracepción hormonal contra demanda | |
| IL188042A0 (en) | Estrogen compositions for vaginal administration | |
| IL188043A0 (en) | Estrogen compositions for vaginal administration | |
| WO2006023496A3 (en) | Vaginal cream compositions, kits thereof and methods of using thereof | |
| NZ615430A (en) | Method for on-demand contraception | |
| TW200726473A (en) | Compositions and methods for treatment of cycle-related symptoms | |
| WO2007076144A3 (en) | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof | |
| MX347237B (es) | Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina. | |
| PL1871669T3 (pl) | Sposób wytwarzania ciekłych preparatów o zawartości ciał stałych | |
| MA32073B1 (fr) | Systeme d'administration de medicament contenant de l'oestradiol | |
| PE20090805A1 (es) | COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL | |
| TW200612962A (en) | Estriol and estetrol prodrugs | |
| WO2009007454A3 (en) | 8-beta-substituted estratrienes as selectively active estrogens | |
| UA35369U (ru) | Способ корригирования липидного гомеостаза у женщин в пременопаузе | |
| TN2010000097A1 (en) | Lyophilized pharmaceutical compositions |